Validation of an appropriate reference gene for normalization of reverse transcription-quantitative polymerase chain reaction data from rectal cancer biopsies.. Validation of an appropriate reference gene for normalization of reverse transcription-quantitative polymerase chain reaction data from rectal cancer biopsies.: Normalization of RT-qPCR data in rectal cancer

Archive ouverte

Ho-Pun-Cheung, Alexandre | Bascoul-Mollevi, Caroline | Assénat, Eric | Bibeau, Frédéric | Boissière-Michot, Florence | Cellier, Dominic | Ychou, Marc | Lopez-Crapez, Evelyne

Edité par CCSD ; Elsevier Masson -

International audience. Gene expression quantification using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) requires data normalization using an invariable reference gene. Here we assessed the stability of 15 housekeeping genes in 31 tumor and normal rectal samples to validate a reliable reference gene for rectal cancer studies. Our data show that 18S and 28S RNA are stably expressed in all samples. Moreover, when used for normalization, 18S, but not 28S, greatly reduced unspecific variations of gene expression due to RNA degradation. These results demonstrate that 18S is an appropriate reference gene for normalization of RT-qPCR data from rectal cancer samples.

Suggestions

Du même auteur

Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization.

Archive ouverte | Ho-Pun-Cheung, Alexandre | CCSD

International audience. BACKGROUND: Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is the gold standard technique for mRNA quantification, but appropriate normalization is required to obtain ...

Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer.

Archive ouverte | Ho-Pun-Cheung, Alexandre | CCSD

PURPOSE: To investigate whether CCND1 genetic variations associated with a constitutive nuclear protein may influence either the pathologic response to preoperative RT or the prognosis in a series of rectal cancer patients. METHOD...

Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)

Archive ouverte | Samalin, Emmanuelle | CCSD

International audience. Background: No treatment option was available for patients with RAS-mutated (RASmt) metastatic colorectal cancer (mCRC) who progress after standard combined chemotherapies at the time of the ...

Chargement des enrichissements...